INTREPId (INTermediate Risk Erection PreservatIon Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martin T. King, MD, PhD
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stamford Hospital
Stamford, Connecticut, United States
- Beth Israel Deaconness Medical Center
Boston, Massachusetts, United States
- Brigham and Women Hospital
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center in Clinical Affiliation With South Shore Hospital
South Weymouth, Massachusetts, United States
- Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
- Xcancer Omaha / Urology Cancer Center
Omaha, Nebraska, United States
- Nyu Long Island
Garden City, New York, United States
- Nyu Langone Health
New York, New York, United States
- Associated Medical Professionals of Ny
Syracuse, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2020
- Primary completion
- 1 Oct 2027
- Completion
- 1 Mar 2028
- Last update posted
- 15 Dec 2025
- Registered enrollment
- 234
- Registry id
- NCT04025372
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.